Heart Failure Hospitalization and Readmission Outcomes

Heart failure (HF) represents a global public health challenge with rising prevalence driven by ageing populations and improved survival after acute cardiac events. Hospitalisation for HF imposes substantial economic and clinical burden due to repeated admissions and extended lengths of stay. Readmission rates within 30 days of discharge often exceed 20 per cent, reflecting complex interactions between patient comorbidity, socio-economic factors and the quality of transitional care. Key determinants of early rehospitalisation include residual haemodynamic instability, inadequate follow-up and non-cardiovascular complications such as renal dysfunction or respiratory infections. Risk trajectories reveal a particularly vulnerable period in the first two weeks after discharge, with gradual risk attenuation over subsequent months. Innovative strategies to mitigate rehospitalisation include structured care management programmes, early outpatient review, standardisation of readmission metrics and advanced remote monitoring technologies. Such interventions seek to harmonise patient-centred approaches with health-system level reforms, aiming to improve outcomes, reduce costs and address disparities across diverse populations.

Research from Nature Portfolio

Recent anatomical analyses of pulmonary vasculature have provided insights into optimising the implantation of pulmonary artery pressure sensors for remote monitoring of heart failure. Detailed measurements of vessel diameter, angulation and sensor depth have informed device selection for the left and right pulmonary arteries, reducing sensor migration and enhancing signal transmission. This work underpins personalised strategies for sensor placement, facilitating early detection of haemodynamic decompensation and thereby decreasing hospitalisation through timely therapeutic adjustments.

Heart Failure Hospitalization and Readmission Outcomes publication trend

The graph below shows the total number of articles in heart failure hospitalization and readmission outcomes across all publications each year (not limited to Nature Index journals).

Technical terms

Heart failure: A clinical syndrome in which the heart cannot pump enough blood to meet the body’s metabolic demands.

Rehospitalisation: Admission to hospital occurring after a recent discharge, often used as a quality-of-care metric.

30-day readmission rate: The proportion of patients who are readmitted to hospital within 30 days of an index discharge.

Pulmonary artery pressure monitor: An implantable device that measures pulmonary artery pressure to guide management of heart failure.

Care navigator: A healthcare professional who coordinates post-discharge care and supports patient engagement with recommended interventions.

References

1. Reducing rehospitalization in cardiac patients: a randomized, controlled trial of a cardiac care management program (“Cardiolotse”) in Germany. BMC Medicine (2024).
2. Impact of the method of calculating 30-day readmission rate after hospitalization for heart failure. Data from the VancOuver CoastAL Acute Heart Failure (VOCAL-AHF) registry. European Heart Journal - Quality of Care and Clinical Outcomes (2024).
3. Anatomical characterization of pulmonary artery and implications to pulmonary artery pressure monitor implantation. Scientific Reports (2023).
4. Trajectories of risk after hospitalization for heart failure, acute myocardial infarction, or pneumonia: retrospective cohort study. The BMJ (2015).
5. Trends in 30-day readmissions following hospitalisation for heart failure by sex, socioeconomic status and ethnicity. EClinicalMedicine (2021).